Muthu, M.; Kumar, R.; Syed Khaja, A.S.; Gilthorpe, J.D.; Persson, J.L.; Nordström, A.
GLUL Ablation Can Confer Drug Resistance to Cancer Cells via a Malate-Aspartate Shuttle-Mediated Mechanism. Cancers 2019, 11, 1945.
https://doi.org/10.3390/cancers11121945
AMA Style
Muthu M, Kumar R, Syed Khaja AS, Gilthorpe JD, Persson JL, Nordström A.
GLUL Ablation Can Confer Drug Resistance to Cancer Cells via a Malate-Aspartate Shuttle-Mediated Mechanism. Cancers. 2019; 11(12):1945.
https://doi.org/10.3390/cancers11121945
Chicago/Turabian Style
Muthu, Magesh, Ranjeet Kumar, Azharuddin Sajid Syed Khaja, Jonathan D. Gilthorpe, Jenny L. Persson, and Anders Nordström.
2019. "GLUL Ablation Can Confer Drug Resistance to Cancer Cells via a Malate-Aspartate Shuttle-Mediated Mechanism" Cancers 11, no. 12: 1945.
https://doi.org/10.3390/cancers11121945
APA Style
Muthu, M., Kumar, R., Syed Khaja, A. S., Gilthorpe, J. D., Persson, J. L., & Nordström, A.
(2019). GLUL Ablation Can Confer Drug Resistance to Cancer Cells via a Malate-Aspartate Shuttle-Mediated Mechanism. Cancers, 11(12), 1945.
https://doi.org/10.3390/cancers11121945